This article in JACC examines the rates of MI in patients with ACS treated with ticagrelor vs clopidogrel.
The rates of overall MI at 12 months:
1. Ticagrelor- 5.8%
2. Clopidogrel – 6.9%
3. Nonprocedural MI (HR: 0.86; 95% CI: 0.74 to 1.01) and MI related to percutaneous coronary intervention or stent thrombosis tended to be lower with ticagrelor.
click here to read more